A global biopharmaceutical company commercializing and developing a portfolio of innovative medicines to serve the unserved rare disease patient.
View our financial calendar and what conferences, meetings, and congresses we will visit in 2025 on our Upcoming Events page.
Download Pharming's most recent quarterly financial results and conference presentations on our Corporate Presentations page.
Wilt u overschakelen naar een andere taal? Klik hier voor de Nederlandse website.